Early Access — free while we kick the tires
EdgarHawk

Walz Andrew Benjamin

President, DM&C

Officer
2 filings analyzed · 1 company · Latest 2026-03-04

Companies

Company Buys Sells Direction
CHEVRON CORP CVX 0 9 Net selling

Activity

March 2026
2026-03-04 CHEVRON CORP CVX
medium
Sell
11,600 shares
$2,187,517
Significance 3/10

Chevron President Walz sells entire 11.6K-share stake for $2.2M in two transactions on 2026-03-02

Andrew Benjamin Walz, President of Chevron's Downstream, Midstream & Chemicals division, executed 2 separate sales on March 2, 2026, liquidating his complete shareholding of 11,600 shares (11.6K shares) at a blended average price of $188.58, generating $2,187,516.96 ($2.2M) in proceeds. The timing occurs near Chevron's 52-week high of $189.60, with the stock currently trading at $186.03 (-1.9% from peak). This represents a complete exit from Chevron equity after holding 11,600 shares pre-transaction, though the insider's cross-ticker track record of 1 prior sell does not establish a measurable historical pattern at this ticker. With Chevron trading at a P/E of 50.14 against a backdrop of -6.8% annual revenue growth, investors should monitor whether additional insider activity follows or whether this reflects portfolio rebalancing unrelated to company-specific positioning.

February 2026
2026-02-05 CHEVRON CORP CVX
high
Sell
22,200 shares
$3,919,050
Significance 6/10

President Walz sells 22,200 CVX shares (97.1% of holdings) for $3.9M at $176.53; retains only 666 shares

Walz Andrew Benjamin, President of DM&C, executed a substantial reduction in Chevron holdings, selling 22,200 shares for $3,919,050.36 on 2026-02-03. The sale represents 97.1% of his pre-transaction holdings, leaving him with only 666 shares post-transaction. The transaction occurred at $176.53, which is 1.1% below the 52-week high of $181.23, and the stock has since appreciated 14.5% over 30 days and 15.6% over 90 days. This near-complete liquidation by a senior insider in a large-cap company with $360.9B market cap is material and warrants scrutiny of the underlying rationale—whether it reflects portfolio-level needs unrelated to the company's outlook or signals a substantive view about CVX valuation relative to alternatives.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access